Dr. Ollar is currently a member and consulting microbiologist for the Pike County Tick Borne Diseases Task Force Committee in Pike County Pennsylvania USA. He also has a faculty appointment as a Clinical Assistant Professor of Neurology in the Department of Neurology of New York Medical College, which is located in Valhalla, New York USA. He had also served the Pennsylvania Department of Health as a member of the special Task Force Committee, on Lyme and Related Tick Borne Diseases which created a Lyme Disease Report. He had served as the Director of the Molecular Biology Lab and Molecular Biology Program for the Departments of Surgery and Neurology at St. Vincentís Hospital Manhattan prior the hospitalís closure on the 30th April 2010. His current research focus is on the problems of misdiagnosis commonly associated with Neuroborreliosis. His specific focus is upon the application of specific microRNAs biomarkers in the early detection of ALS, MS and Alzheimerís Disease, Parkinsonís Disease, and the potential of these biomarkers to distinguish true forms of the aforementioned neurodegenerative diseases, from cases manifesting clinical symptoms mimicking those illnesses. In addition, he is interested in the application of advanced RNA biomarkers that could utilized to monitor: a) pathogen load, b) clearance of pathogens from patent as relates to the efficacy of specific anti-microbial ,anti-parasitic and anti-viral agents. During the course of his thirty year professional career, he has pursued research interests in such diverse areas as: Mycobacteriology and Molecular Mycobacteriology in TB and AIDS-related Non-Tuberculous Mycobacterial Pathogens, Cholera Neuraminidase, Amytrophic Lateral Sclerosis, and the application of molecular markers for early detection in Pancreatic Cancer.
During the course of his forty six year professional career, Dr Ollar has pursued research interests in such diverse areas as: Biology of Nocardial Organisms, Mycobacteriology and Molecular Mycobacteriology in TB and AIDS-related Non-Tuberculous Mycobacterial Pathogens, Cholera Neuraminidase, Amytrophic Lateral Sclerosis, the application of molecular markers for early detection in Pancreatic Cancer, and Lyme Neuroborreliosis Mimicry.